Citius Pharmaceuticals Completes Enrollment in Pivotal Phase 3 Trial of its Mino-Lok® Therapeutic to Salvage Catheters ...Middle East

Topline results expected 2Q 2024 Study enrolled a total of 241 patients; 109 catheter failures observed First-and-only antibiotic lock solution in development to salvage catheters in patients with CRBSI CRANFORD, N.J., Jan. 2, 2024 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or...

Read More Details
Finally We wish PressBee provided you with enough information of ( Citius Pharmaceuticals Completes Enrollment in Pivotal Phase 3 Trial of its Mino-Lok® Therapeutic to Salvage Catheters )

Also on site :

• A look at six bills in Albany awaiting Gov. Hochul’s signature
• Israel tried to break Iran – but it may have actually helped unite it
• This 'Iconic' Cereal is Finally Making a Comeback and Fans Going Wild: 'Holy Smokes'